In addition, they have updated the analyses to include the complete resource utilization and cost data that are newly available through 10 years of combined DPP/DPPOS follow-up.
[3] [5] We here update the meta-analyses to provide a quantitative comparison between the two types of study and investigate a possible explanation (based on concomitant use of antiplatelet therapy in the trials) that could explain the discrepant results.
We update the earlier longitudinal analyses using CPS data through 2009, which was the latest year available at the time this research was done (the period covered by the ASEC files extended through 2008, versus 2009 for the MORG files).
In order to update the results, we analysed the characteristics of all statin initiators with diabetes in 2010 (N=12 541).We did not observe any appreciable changes in the age profile, proportion of men, proportion of those with medically treated hypertension or the proportion of patients with CVD, nor in the mean duration of diabetes (data not shown).
Many studies reported other outcomes for urinary catheter use (detailed in table 2), but none of the studies identified since the prior meta-analysis provided sufficient detail (eg, number of patients in intervention or control groups, and measures of variability such as SD) to update the prior meta-analyses for these other urinary catheter use outcomes.
This makes it hard to use the underlying data to inform evidence-based decisions, to verify the analyses, to update the review or to perform a combined analysis of several reviews for an umbrella review.
It is questionable whether updating the meta-analyses to include them is worthwhile.
Updating the meta-analyses lead to a more precise estimate of the likely effect of the nicotine patch, but the clinical message was unchanged.
This geodatabase also has analysis functions developed in the ArcGIS 9 software environment that are used to update the overall constraints map, to analyse sensitivity with respect to constraint criteria-defining parameters as well as to perform full diagnostic studies on wind farm projects.
We therefore updated the cost-effectiveness analyses of RV vaccination for the Netherlands assuming absence of differences between the two vaccines.
